The Neurocare Center for Research efficiently and expertly evaluates promising new medicines and also diagnostic and treatment devices for patients with sleep, neurologic, psychiatric, respiratory, and other health conditions including obesity, arthritis, high blood pressure, hypercholesterolemia and diabetes. A more complete list is on our Neurocare Website (neurocarecenterforresearch.com). Our sponsors include some of the most innovative and successful companies in the world.

Our highly qualified professionals have successfully completed sponsor and principal investigator-initiated Phase II-IV clinical trials for ten years.  We are licensed to evaluate Schedule I-VI medications and INDs.  By the beginning of the new year we will have an additional trial site in Brookline, Phase I trials capability, and added physician investigators, enabling us to expand our research scope.  Our Brookline facility is directly adjacent to a major Boston trolley line making it accessible to patients who prefer the use of public transportation.

As an independent research site, using a central IRB and with minimal bureaucracy, we expedite our clinical trials from initiation to close out.  We help reduce our clients’ costs by providing quick turnaround and quality data.  We offer subjects treatment opportunities that may not be available elsewhere.  Our convenient state-of-the-art facilities incorporate an American Academy of Sleep Medicine accredited sleep disorders center and ACRP-certified coordinators with over 50 years of combined research experience.